| | | | | | | | | | | | | | | | |
| | |
 | Issue Date FY: 2024 ( Subtotal = $0 ) |
| | 2024 | 2022 | VAXSYNA, INC. | 45 CIRCLE DR | FRANKLIN | NH | 03235-1551 | MERRIMACK | USA | R41CA271851 | Low cost, Broad Spectrum Cancer Vaccine Targeting Human Papillomavirus | 000 | 1 | NIH | 3/19/2024 | $0 |
| | 2024 | 2022 | VAXSYNA, INC. | 45 CIRCLE DR | FRANKLIN | NH | 03235-1551 | MERRIMACK | USA | R41CA271851 | Low cost, Broad Spectrum Cancer Vaccine Targeting Human Papillomavirus | 001 | 1 | NIH | 3/20/2024 | $0 |
|
| Issue Date FY: 2023 ( Subtotal = $0 ) |
| | 2023 | 2022 | VAXSYNA, INC. | 45 CIRCLE DR | FRANKLIN | NH | 03235-1551 | MERRIMACK | USA | R41CA271851 | Low cost, Broad Spectrum Cancer Vaccine Targeting Human Papillomavirus | 001 | 1 | NIH | 1/27/2023 | $0 |
| | 2023 | 2022 | VAXSYNA, INC. | 45 CIRCLE DR | FRANKLIN | NH | 03235-1551 | MERRIMACK | USA | R41CA271851 | Low cost, Broad Spectrum Cancer Vaccine Targeting Human Papillomavirus | 000 | 1 | NIH | 11/18/2022 | $0 |
|
| Issue Date FY: 2022 ( Subtotal = $437,203 ) |
| | 2022 | 2022 | VAXSYNA, INC. | 45 CIRCLE DR | FRANKLIN | NH | 03235-1551 | MERRIMACK | USA | R41CA271851 | Low cost, Broad Spectrum Cancer Vaccine Targeting Human Papillomavirus | 002 | 1 | NIH | 9/19/2022 | $121,329 |
| | 2022 | 2022 | VAXSYNA, INC. | 45 CIRCLE DR | FRANKLIN | NH | 03235-1551 | MERRIMACK | USA | R41CA271851 | Low cost, Broad Spectrum Cancer Vaccine Targeting Human Papillomavirus | 001 | 1 | NIH | 9/13/2022 | -$315,874 |
| | 2022 | 2022 | VAXSYNA, INC. | 45 CIRCLE DR | FRANKLIN | NH | 03235-1551 | MERRIMACK | USA | R41CA271851 | Low cost, Broad Spectrum Cancer Vaccine Targeting Human Papillomavirus | 001 | 1 | NIH | 9/13/2022 | $315,874 |
| | 2022 | 2022 | VAXSYNA, INC. | 45 CIRCLE DR | FRANKLIN | NH | 03235-1551 | MERRIMACK | USA | R41CA271851 | Low cost, Broad Spectrum Cancer Vaccine Targeting Human Papillomavirus | 000 | 1 | NIH | 3/24/2022 | $315,874 |
|
|
